PainTEQ Receives Two New Patents for the LinQ® Procedure, Advancing Treatments for SI Joint Dysfunction
May 2, 2024
PainTEQ has been awarded two new patents for our LinQ® procedure, bringing our total number of patents to 14.
Outcomes of a Posterior Approach to SI Joint Fusion with LinQ® Reflect Clinical Efficacy and Durability at 12 Months
March 20, 2024
SI joint fusion with PainTEQ's LinQ SI Joint Stabilization System shows promise for treating patients with sacroiliac joint dysfunction.
PainTEQ Announces Successful Completion of First In-office LinQ Procedure Under New CMS Billing Code
January 18, 2024
The first in-office LinQ procedure was successfully completed on January 17, 2024, by Nomen Azeem, MD.
Patent Trial and Appeal Board Sides with PainTEQ in the Orthocision IPR Case
December 21, 2023
Judges of the Patent Trial Appeal Board (PTAB) unanimously sided with PainTEQ in a recent IPR trial with Orthocision.
CMS Finalizes New Billing Code for Posterior SI Joint Fusion to Be In-office Procedure
November 3, 2023
CMS finalized its decision to establish payment rates for posterior SI joint fusion in the office setting.
PainTEQ Launches World’s First Surgery-Ready Instruments for Posterior Approach with LinQ
September 6, 2023
The third-generation surgical instrument set for PainTEQ’s LinQ procedure includes single-use, surgery-ready instruments, offering a safer and more cost-effective option for interventional pain physicians.
